APA (7th ed.) Citation

RA, M., WY, L., A, G., AR, N., EK, W., SM, K., . . . AS, A. (2022). GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2. Pathogens (Basel, Switzerland), 11(7), . https://doi.org/10.3390/pathogens11070806

Chicago Style (17th ed.) Citation

RA, Mizrahi, et al. "GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2." Pathogens (Basel, Switzerland) 11, no. 7 (2022). https://doi.org/10.3390/pathogens11070806.

MLA (9th ed.) Citation

RA, Mizrahi, et al. "GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2." Pathogens (Basel, Switzerland), vol. 11, no. 7, 2022, https://doi.org/10.3390/pathogens11070806.